Clinical Trial Detail

NCT ID NCT03656627
Title Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alliance Foundation Trials, LLC.
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.